nyc-e

Hi Geert, thanks for taking the time to do this. We've seen CROs administering other multi-thousand-patient, multi-year Phase 3 cancer trials take 8 or perhaps 10 weeks for the data scrubbing process. Given the scope of IT-MATTERS is certainly larger than most, do your conversations with the CRO indicate a delay of further weeks, or could it be months? Could we not have a topline release til 2021?

Apologies for the similar question to others, but after this many years of wait, it's important to know.

Despite this, you must be in constant contact with the CRO, as most management teams are with theirs that allow them to guide the street to a Q3 or Q4 release, for instance. Since you will wait for full data release (vs. just topline), could a delay until 2021 be in the cards? Or can you guess that it would come before year end?